Cargando…
Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches
BACKGROUND: Canine MuStem cells have demonstrated regenerative efficacy in a dog model of muscular dystrophy, and the recent characterization of human counterparts (hMuStem) has highlighted the therapeutic potential of this muscle-derived stem cell population. To date, these cells have only been gen...
Autores principales: | Saury, Charlotte, Lardenois, Aurélie, Schleder, Cindy, Leroux, Isabelle, Lieubeau, Blandine, David, Laurent, Charrier, Marine, Guével, Laëtitia, Viau, Sabrina, Delorme, Bruno, Rouger, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932844/ https://www.ncbi.nlm.nih.gov/pubmed/29720259 http://dx.doi.org/10.1186/s13287-018-0852-y |
Ejemplares similares
-
Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways
por: Charrier, Marine, et al.
Publicado: (2022) -
Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation
por: Robriquet, Florence, et al.
Publicado: (2015) -
Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function
por: Rannou, Alice, et al.
Publicado: (2020) -
Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation
por: Robriquet, Florence, et al.
Publicado: (2016) -
Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits
por: Lorant, Judith, et al.
Publicado: (2018)